Citation Information :
Viewpoint: Weak Scientific Basis for the Recommendation of Executive Summary of Surviving Sepsis Campaign Guidelines 2021. Indian J Crit Care Med 2022; 26 (8):898-899.
The Executive summary of Sepsis 2021 was published recently, which for the first time, recommended that in septic shock, the vasopressor infusion should be commenced through a peripherally inserted venous catheter (PiVC) for up to 6 hours. We discuss the scientific basis for such a recommendation regarding the safety of vasopressor infusion through a peripherally inserted vascular catheter or the accepted duration.
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Executive summary: surviving sepsis campaign: International guidelines for the management of sepsis and septic shock 2021. Crit Care Med 2021;49(11):1974–1982. DOI: 10.1097/CCM.0000000000005357.
Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 2021;49(11):e1063–e1143. DOI: 10.1097/CCM.0000000000005337.
Nath SS, Nachimuthu N. Oversight in executive summary of sepsis guidelines 2021. Crit Care Med 2022;50(7):e649. DOI: 10.1097/CCM.0000000000005522.
Loubani OM, Green RS. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care 2015;30(3):653.e9–653.17. DOI: 10.1016/j.jcrc.2015.01.014.
Tian DH, Smyth C, Keijzers G, Macdonald SP, Peake S, Udy A, et al. Safety of peripheral administration of vasopressor medications: a systematic review. Emerg Med Australas 2020;32(2):220–227. DOI: 10.1111/1742-6723.13406.
Djogovic D, MacDonald S, Wensel A, Green R, Loubani O, Archambault P, et al. Vasopressor and inotrope use in Canadian emergency departments: evidence-based consensus guidelines. CJEM 2015;17(1):1–2. DOI: 10.1017/cem.2014.77.
Delaney A, Finnis M, Bellomo R, Udy A, Jones D, Keijzers G, et al. Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study. Emerg Med Australas 2020;32(2):210–219. DOI: 10.1111/1742-6723.13394.
Lewis T, Merchan C, Altshuler D, Papadopoulos J. Safety of the peripheral administration of vasopressor agents. J Intensive Care Med 2019;34(1):26–33. DOI: 10.1177/0885066616686035.
Ricard JD, Salomon L, Boyer A. Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med 2013;41(9):2108–2115. DOI: 10.1097/CCM.0b013e31828a42c5.
Beck V, Chateau D, Bryson GL, Pisipati A, Zanotti S, Parrillo JE, et al. Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care 2014;18(3):R97. DOI: 10.1186/cc13868.
